JPS648307B2 - - Google Patents
Info
- Publication number
- JPS648307B2 JPS648307B2 JP9443083A JP9443083A JPS648307B2 JP S648307 B2 JPS648307 B2 JP S648307B2 JP 9443083 A JP9443083 A JP 9443083A JP 9443083 A JP9443083 A JP 9443083A JP S648307 B2 JPS648307 B2 JP S648307B2
- Authority
- JP
- Japan
- Prior art keywords
- polyethylene glycol
- reagent
- present
- mixed solution
- irregular antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001223 polyethylene glycol Polymers 0.000 claims description 25
- 239000002202 Polyethylene glycol Substances 0.000 claims description 24
- 230000001788 irregular Effects 0.000 claims description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- 229910019142 PO4 Inorganic materials 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 9
- 239000010452 phosphate Substances 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 8
- 239000000872 buffer Substances 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002736 nonionic surfactant Substances 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 4
- 206010049190 Red blood cell agglutination Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- -1 fatty acid ester Chemical class 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Description
本発明は状態の異なるポリエチレングリコール
をリン酸塩食塩緩衝液に溶解させて得たポリエチ
レングリコールの混合溶液からなる不規則抗体の
検出用試薬に関する。
不規則抗体とはいわゆるランドスタイナー
(Landsteiner)の法則に合わない赤血球抗体のこ
とで、抗D、抗C、抗、抗E、抗Dia、抗S、
抗Jra、抗Xga、抗Fybなどが知られている。この
ような不規則抗体を検出する従来法の1つにアル
ブミン・クームス法があり、その術式を例示する
と次の通りである。
試験管にセレクトゲン(不規則抗体に対応する
抗原をもつヒトO型赤血球の浮遊液)1適と被検
血清2滴を入れ、これに22%ウシアルブミン溶液
を2滴加えて37℃で15〜30分間感作する。このも
のを生理食塩水を用いて2500rpm、5分間の遠心
で3回洗浄した後、上澄みをできるだけ捨て去
る。次にクームス血清を2滴加えて1000rpmで1
分間遠心し、赤血球の凝集の強さを肉眼で判定す
る。このアルブミン・クームス法は22%ウシアル
ブミン溶液とクームス血清を必要とし、クームス
血清が高価であるという欠点がある。
本発明の目的は安価で検出精度の良い不規則抗
体の検出用試薬を提供することにある。
本発明者はウシアルブミンやクームス血清に代
る不規則抗体の検出用試薬を研究し、入手が容易
でしかも安価なグリース状ないしワツクス状のポ
リエチレングリコールが、22%ウシアルブミン溶
液及びクームス血清と同等又はそれ以上の機能を
有することを見出し、この知見に基づいて先に不
規則抗体の検査用試薬(特願昭57―165313号、先
行発明という)を開発した。本発明者は引続いて
ポリエチレングリコールを用いる検出用試薬の研
究を重ねた結果、状態の異なるポリエチレングリ
コールの混合溶液が先行発明よりも優れた機能を
有することを見出し、又このポリエチレングリコ
ールの混合溶液に非イオン性界面活性剤を加える
と赤血球の凝集像が見やすくなることを見出し、
これらの新知見に基づいて本発明を完成した。
本発明に係る検出用試薬は状態の異なるポリエ
チレングリコールをリン酸塩食塩緩衝液に溶解さ
せて得たポリエチレングリコールの混合溶液であ
り、次にその実施例を説明する。
本発明におけるリン酸塩食塩緩衝液はリン酸塩
の濃度1/75モルのものが適し、これに0.8%の割
合で食塩を溶解させておく。このリン酸塩食塩緩
衝液に非イオン性界面活性剤例えばポリオキシエ
チレンソルビタン脂肪酸エステルを0.2%の割合
に溶解させる。ポリエチレングリコールの溶剤に
このような界面活性剤を加えておくと、赤血球が
試験管の内壁に付着しなくなり、遠心沈澱により
赤血球が試験管底に落とされるので、赤血球の凝
集像が見やすくなり、従つて検出精度が向上す
る。
状態の異なるポリエチレングリコール(PEG
と略記する)はグリース状ないしワツクス状とフ
レーク状及び液状のものを用い、これらのPEG
を上記リン酸塩食塩緩衝液に次の濃度となるよう
に溶解させる。
平均分子量6000のワツクス状PEG 4.5〜10.0%
平均分子量20000のフレーク状PEG 0.5〜1.2%
平均分子量400の液状PEG 0〜7.0%
本発明試薬を用いる不規則抗体の検出法(本発
明法という)について、その術式を具体的に例示
すると次の通りである。
PEG#6000と#20000及び#400を上記リン酸
塩食塩緩衝液にそれぞれ濃度6%、0.9%、2%
となるように溶解させ、これに上記界面活性剤を
0.2%の割合に溶解させて本発明試薬を調製する。
試験管にセレクトゲン1滴と被検血清2滴を入
れ、これに本発明試薬2滴を加え、37℃で15〜30
分間感作する。このものを生理食塩水を用いて
2500rpm、5分間の遠心で2回洗浄し、上澄みを
捨て去る。次に本発明試薬を2滴加えて3400rpm
で15秒間遠心し、赤血球の凝集の強さを肉眼で判
定する。
従来のアルブミン・クームス法と先行発明法及
び本発明法について幾つかの不規則抗体に対する
反応性を比較した。その成績は第1表の通りであ
る。なお凝集スコアはダンスフオードとボウレイ
(Dunsford and Bowly)の方法に従つて(4+)
から(0)までの6段階に分けて計算した。
The present invention relates to a reagent for detecting irregular antibodies comprising a mixed solution of polyethylene glycol obtained by dissolving polyethylene glycol in different states in a phosphate saline buffer. Irregular antibodies are red blood cell antibodies that do not conform to Landsteiner's law, such as anti-D, anti-C, anti-E, anti- Dia , anti-S,
Anti- Jra , anti- Xga , anti-Fy b, etc. are known. One of the conventional methods for detecting such irregular antibodies is the albumin Coombs method, and an example of the technique is as follows. Put 1 drop of Selectogen (a suspension of human type O red blood cells containing antigens corresponding to irregular antibodies) and 2 drops of test serum into a test tube, add 2 drops of 22% bovine albumin solution, and incubate at 37°C for 15 minutes. Sensitize for ~30 min. After washing this product three times with physiological saline by centrifugation at 2500 rpm for 5 minutes, discard as much of the supernatant as possible. Next, add 2 drops of Coombs serum and run at 1000 rpm.
Centrifuge for a minute and visually judge the strength of red blood cell agglutination. This albumin-Coombs method requires 22% bovine albumin solution and Coombs serum, and has the disadvantage that Coombs serum is expensive. An object of the present invention is to provide a reagent for detecting irregular antibodies that is inexpensive and has high detection accuracy. The present inventor has researched reagents for detecting irregular antibodies as an alternative to bovine albumin and Coombs serum, and found that easily available and inexpensive grease-like or wax-like polyethylene glycol is equivalent to 22% bovine albumin solution and Coombs serum. Based on this knowledge, we developed a reagent for testing irregular antibodies (Japanese Patent Application No. 165313/1986, referred to as prior invention). As a result of successive research on detection reagents using polyethylene glycol, the present inventor discovered that a mixed solution of polyethylene glycol in different states had superior functionality than the prior invention, and also found that this mixed solution of polyethylene glycol discovered that adding a nonionic surfactant to the erythrocyte aggregation image made it easier to see the agglutination image of red blood cells.
The present invention was completed based on these new findings. The detection reagent according to the present invention is a mixed solution of polyethylene glycol obtained by dissolving polyethylene glycol in different states in a phosphate saline buffer, and examples thereof will be described next. A suitable phosphate saline buffer in the present invention has a phosphate concentration of 1/75 molar, and salt is dissolved therein at a ratio of 0.8%. A nonionic surfactant such as polyoxyethylene sorbitan fatty acid ester is dissolved in this phosphate saline buffer at a ratio of 0.2%. Adding such a surfactant to the polyethylene glycol solvent prevents red blood cells from adhering to the inner wall of the test tube, and centrifugal sedimentation causes the red blood cells to fall to the bottom of the test tube, making it easier to see red blood cell agglutination images. As a result, detection accuracy improves. Polyethylene glycol (PEG) in different states
(abbreviated as PEG) is in the form of grease, wax, flakes, and liquid.
is dissolved in the above phosphate saline buffer to the following concentration: Waxy PEG with an average molecular weight of 6,000 4.5-10.0% Flake-like PEG with an average molecular weight of 20,000 0.5-1.2% Liquid PEG with an average molecular weight of 400 0-7.0% Regarding the method for detecting irregular antibodies using the reagent of the present invention (referred to as the method of the present invention) A specific example of the technique is as follows. PEG #6000, #20000 and #400 were added to the above phosphate saline buffer at concentrations of 6%, 0.9% and 2%, respectively.
Dissolve and add the above surfactant to it.
The reagent of the present invention is prepared by dissolving it at a ratio of 0.2%.
Put 1 drop of selectogen and 2 drops of test serum into a test tube, add 2 drops of the reagent of the present invention, and incubate at 37℃ for 15-30 minutes.
Sensitize for minutes. Use this with physiological saline
Wash twice by centrifuging at 2500 rpm for 5 minutes, and discard the supernatant. Next, add 2 drops of the reagent of the present invention and turn the temperature at 3400 rpm.
Centrifuge for 15 seconds and visually judge the strength of red blood cell agglutination. The reactivity of the conventional albumin Coombs method, the prior invention method, and the present invention method to several irregular antibodies was compared. The results are shown in Table 1. The agglomeration score was calculated according to Dunsford and Bowly's method (4+).
The calculation was divided into six stages from (0) to (0).
【表】【table】
【表】
第1表から判るように試験に用いた抗Eは従来
法では検出不能であり、プロメリン法で始めて検
出可能であつたが、本発明法により容易に検出で
きた。本発明法は抗Eのほか第1表に記載した通
り多くの不規則抗体を検出することができた。検
出の感度は抗E、抗Dと抗については従来法よ
りも本発明法の方が感度が良く、抗Jraは本発明
法に比較して従来法の方が感度が良かつたが、そ
の他の抗体では両法とも同じ感度を示した。又先
行発明法では抗体価の低い抗S、抗Xga、抗Jra
は検出不能であつたが、本発明法はこれらの不規
則抗体をも検出することができた。
以上は本発明に係る試薬の実施例及びこれを用
いる不規則抗体検出法の1例を示したもので、本
発明はこれらに限定されることなく、発明の要旨
内において、用いるポリエチレングリコールを変
更することができ、例えばポリエチレングリコー
ルについては#6000のものを#4000に、#20000
のものを#11000に、又#400のものを#300に代
えてもよく、この場合混合溶液中における各ポリ
エチレングリコールの濃度をその平均分子量に応
じて変更することができる。
本発明に係る検出用試薬は状態の異なるポリエ
チレングリコールを、リン酸塩食塩緩衝液に溶解
させて混合溶液を調製したもので、入手が容易で
しかも安価なポリエチレングリコールを用いて不
規則抗体を検出し、従来のアルブミン・クームス
法と同等又はそれ以上の成績を挙げることができ
るから、不規則抗体の検出用試薬として極めて有
益である。又リン酸塩緩衝液に非イオン性界面活
性剤を加えたものは検出精度がさらに向上すると
いう利点を有す。[Table] As can be seen from Table 1, the anti-E used in the test was undetectable by the conventional method and could only be detected by the promelin method, but it was easily detected by the method of the present invention. The method of the present invention was able to detect many irregular antibodies as listed in Table 1 in addition to anti-E. Regarding detection sensitivity, the method of the present invention was more sensitive than the conventional method for anti-E, anti-D, and anti-anti, and the conventional method was more sensitive than the method of the present invention for anti-Jr a . For other antibodies, both methods showed the same sensitivity. In addition, the prior invention method uses anti-S, anti-Xg a , anti-Jr a with low antibody titers.
were undetectable, but the method of the present invention was also able to detect these irregular antibodies. The above shows an example of the reagent according to the present invention and an example of the method for detecting irregular antibodies using the same, and the present invention is not limited thereto, and the polyethylene glycol used may be changed within the gist of the invention. For example, for polyethylene glycol, #6000 can be #4000, #20000
#11000 may be used instead of #400, and #300 may be used instead of #400. In this case, the concentration of each polyethylene glycol in the mixed solution can be changed depending on its average molecular weight. The detection reagent according to the present invention is a mixed solution prepared by dissolving polyethylene glycol in different states in a phosphate saline buffer, and detects irregular antibodies using easily available and inexpensive polyethylene glycol. However, it is extremely useful as a reagent for detecting irregular antibodies because it can achieve results equivalent to or better than the conventional albumin-Coombs method. Furthermore, the addition of a nonionic surfactant to the phosphate buffer has the advantage of further improving detection accuracy.
Claims (1)
び液状の各ポリエチレングリコールを、リン酸塩
食塩緩衝液に溶解させて得た状態の異なるポリエ
チレングリコールの混合溶液からなることを特徴
とする不規則抗体の検出用試薬。 2 グリース状ないしワツクス状とフレーク状及
び液状の各ポリエチレングリコールを、リン酸塩
食塩緩衝液にそれぞれ4.5〜10.0%、0.5〜1.2%、
0〜7.0%の濃度となるように溶解させて混合溶
液を調製した特許請求の範囲第1項に記載の不規
則抗体の検出用試薬。 3 ポリエチレングリコールの混合溶液に非イオ
ン性界面活性剤を加えた特許請求の範囲第1項又
は第2項に記載の不規則抗体の検出用試薬。[Claims] 1. A mixed solution of polyethylene glycol in different states obtained by dissolving each of grease-like, wax-like, flake-like, and liquid polyethylene glycol in a phosphate-salt buffer. Reagent for detection of irregular antibodies. 2 Grease-like, wax-like, flake-like, and liquid polyethylene glycols were added to a phosphate saline buffer solution at 4.5-10.0% and 0.5-1.2%, respectively.
The reagent for detecting irregular antibodies according to claim 1, wherein a mixed solution is prepared by dissolving the antibodies to a concentration of 0 to 7.0%. 3. The reagent for detecting irregular antibodies according to claim 1 or 2, wherein a nonionic surfactant is added to a mixed solution of polyethylene glycol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9443083A JPS59218958A (en) | 1983-05-27 | 1983-05-27 | Reagent for detecting irregular antibody |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9443083A JPS59218958A (en) | 1983-05-27 | 1983-05-27 | Reagent for detecting irregular antibody |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59218958A JPS59218958A (en) | 1984-12-10 |
| JPS648307B2 true JPS648307B2 (en) | 1989-02-13 |
Family
ID=14110014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9443083A Granted JPS59218958A (en) | 1983-05-27 | 1983-05-27 | Reagent for detecting irregular antibody |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59218958A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3012407U (en) * | 1994-12-14 | 1995-06-20 | 株式会社トキワ | Cartridge type compact |
| US7874271B2 (en) | 2005-09-23 | 2011-01-25 | Jp Scope Llc | Method of operating a valve apparatus for an internal combustion engine |
| US8528511B2 (en) | 2005-09-23 | 2013-09-10 | Jp Scope, Inc. | Variable travel valve apparatus for an internal combustion engine |
| WO2020096029A1 (en) * | 2018-11-09 | 2020-05-14 | 積水メディカル株式会社 | Method for suppressing abnormal detection in immunoassay by automatic analysis device, and immunoassay reagent |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62159047A (en) * | 1985-12-31 | 1987-07-15 | Chemo Sero Therapeut Res Inst | Reagent for quantitative determination of plasma protein |
| DE10034496A1 (en) * | 2000-07-13 | 2002-01-31 | Olympus Diagnostica Gmbh | Blood group serological examination procedure |
| CN102338800A (en) * | 2011-05-25 | 2012-02-01 | 上海血液生物医药有限责任公司 | Antibody screening erythrocyte kit |
-
1983
- 1983-05-27 JP JP9443083A patent/JPS59218958A/en active Granted
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3012407U (en) * | 1994-12-14 | 1995-06-20 | 株式会社トキワ | Cartridge type compact |
| US7874271B2 (en) | 2005-09-23 | 2011-01-25 | Jp Scope Llc | Method of operating a valve apparatus for an internal combustion engine |
| US8516988B2 (en) | 2005-09-23 | 2013-08-27 | Jp Scope, Inc. | Valve apparatus for an internal combustion engine |
| US8528511B2 (en) | 2005-09-23 | 2013-09-10 | Jp Scope, Inc. | Variable travel valve apparatus for an internal combustion engine |
| US8899205B2 (en) | 2005-09-23 | 2014-12-02 | Jp Scope, Inc. | Valve apparatus for an internal combustion engine |
| WO2020096029A1 (en) * | 2018-11-09 | 2020-05-14 | 積水メディカル株式会社 | Method for suppressing abnormal detection in immunoassay by automatic analysis device, and immunoassay reagent |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59218958A (en) | 1984-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3714345A (en) | Stabilized erythrocyees and methods therefore | |
| US4108974A (en) | Radioimmunoassay for thyroid hormone | |
| JPS6255103B2 (en) | ||
| EP1957978B1 (en) | Magnetic immunodiagnostic method for the demonstration of antibody/antigen complexes especially of blood groups | |
| JPS648307B2 (en) | ||
| TW201348707A (en) | Reagent set for matching test before blood transfusion and testing method thereof | |
| SU1091844A3 (en) | Diagnosticum for finiding agtigene of hepathitis b | |
| EP1745290A2 (en) | Use of ferrofluids for phenotyping blood and related applications | |
| CN104569443A (en) | Rh blood type detecting card | |
| CN113252914B (en) | Antibody diluent for Rh system parting detection card and detection card | |
| CN115541891A (en) | Allergen-specific IgE antibody detection kit and preparation method thereof | |
| JP2682697B2 (en) | Immunoassay reagents and immunoassays | |
| JPH01129163A (en) | Diagnosis reagent of apolipoprotein b and measurement thereof | |
| PT1386160E (en) | Method for detecting blood cell antigens and the antibodies in response to the same | |
| CA2474714C (en) | Automated process for preparing treated microparticles, especially blood cell components | |
| EP0122620A2 (en) | Reagent and kit for determination of blood coagulation factor XIII | |
| CN106645749B (en) | Hemolytic agent and application | |
| CA2088404C (en) | Method for the determination of antigens or antibodies in the presence of an immune complex | |
| CN107543922A (en) | A kind of centrichromatography fluorescence immunoassay detection technique and application thereof | |
| US4460694A (en) | Bovine glycoproteins and use in diagnosing infectious mononucleosis | |
| EP0022669B2 (en) | Method and reagent for blood typing and method for preparing this reagent | |
| JP4547110B2 (en) | Whole blood immunoassay method | |
| CN112326954A (en) | Homogeneous fluoroimmunoassay reagent for rapidly and quantitatively detecting D-dimer | |
| JPH0251150B2 (en) | ||
| US4525459A (en) | New purified glycoproteins and use in diagnosing infectious mononucleosis |